InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Aubrey Rankin, President, Innovation & Tech, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 4 open-market SEC Form 4 transactions: 1 purchase worth $433K and 3 sales worth $2.9M, reported from Jul 26, 21 to Dec 3, 21. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 3, 21 | RVNCRevance Therapeutics, Inc. | BUY | 30.0K | $14.43 | $433K |
| Aug 16, 21 | RVNCRevance Therapeutics, Inc. | SELL | 9.4K | $26.34 | $247K |
| Jul 28, 21 | RVNCRevance Therapeutics, Inc. | SELL | 34.3K | $30.15 | $1.0M |
| Jul 26, 21 | RVNCRevance Therapeutics, Inc. | SELL | 55.4K | $29.72 | $1.6M |